Iga Nephropathy
📧 Sign up to get email alerts when something new happens for Iga Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of Abelmoschus Manihot for IgA Nephropathy; current status is unknown.
-
CLINICAL_TRIALS research · 2016-03-18Clinical Trial Update: Integrative Medicine of IgA Nephropathy [NA]
This clinical trial entry concerns integrative medicine for IgA nephropathy led by Shanghai University of Traditional Chinese Medicine, with…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: An Multi-site Prospective Study to Assess the Efficacy and Safety of MMF in the Treatment of Proliferative IgA Nephropathy(IgAN) [NA]
A multi-site prospective study assessing the efficacy and safety of mycophenolate mofetil (MMF) for proliferative IgA nephropathy has comple…
-
CLINICAL_TRIALS research · 2016-02-02Clinical Trial Update: Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy [Phase 2, Phase 3]
Clinical trial update on the validity and security of Reh-acteoside therapy for IgA nephropathy, involving Phase 2 and Phase 3 studies.
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy: a Self- Controlled Study [Phase 4]
Phase 4 self-controlled study assessing hydroxychloroquine sulfate for reducing proteinuria in patients with IgA nephropathy; the trial has …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-10-23Clinical Trial Update: Open Label Study of Fostamatinib in the Treatment of IgA Nephropathy [Phase 2]
Phase 2 open-label study of fostamatinib for IgA nephropathy has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-10-08Clinical Trial Update: Rituximab in Recurrent IgA Nephropathy [Phase 4]
Phase 4 clinical trial update studying Rituximab for recurrent IgA nephropathy.
-
CLINICAL_TRIALS trial_result · 2015-09-24Clinical Trial Update: The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease [Phase 2]
This update reports completion of a Phase 2 study evaluating Nefecon in patients with Primary IgA Nephropathy at risk of progressing to end-…
-
CLINICAL_TRIALS trial_result · 2015-09-22Clinical Trial Update: Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy [Phase 3]
Phase 3 trial comparing supportive therapy versus immunosuppressive therapy for progressive IgA nephropathy completed.
-
CLINICAL_TRIALS trial_result · 2015-08-20Clinical Trial Update: Biomarkers for the Progression of IgA Nephropathy
A completed clinical trial from Istanbul University studied biomarkers for the progression of IgA nephropathy and related glomerular disease…
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Autonomic Nervous System (ANS) and Renal Function in Immunoglobin A (IgA) Nephropathy [NA]
The trial update indicates completion of a clinical study studying autonomic nervous system functioning and renal function in IgA nephropath…
-
CLINICAL_TRIALS research · 2015-08-19Clinical Trial Update: A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA Nephropathy
A completed clinical trial survey examining factors that influence whether IgA Nephropathy is diagnosed early or late.
-
CLINICAL_TRIALS withdrawal · 2015-08-03Clinical Trial Update: Paricalcitol for the Treatment of Immunoglobulin A Nephropathy [Phase 3]
Phase 3 trial evaluating paricalcitol for immunoglobulin A nephropathy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-07-30Clinical Trial Update: BRILLIANT-SC: A Study of the Efficacy and Safety of Blisibimod Administration in Subjects With IgA Nephropathy [Phase 3]
Anthera Pharmaceuticals has withdrawn the Phase 3 BRILLIANT-SC trial evaluating blisibimod for IgA nephropathy.
-
CLINICAL_TRIALS trial_result · 2015-07-09Clinical Trial Update: The Correlation of Periostin and Renal Pathology in Chronic Kidney Disease Patients
A completed clinical trial update examining the relationship between periostin levels and renal pathology in chronic kidney disease, includi…
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: Aliskiren for Proteinuric IgAN Despite Angiotensin Blockade [Phase 4]
Phase 4 clinical trial evaluating aliskiren for proteinuric IgA nephropathy despite angiotensin blockade has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-02Clinical Trial Update: Prospective Study of TW in Treatment of IgAN With Asymptomatic Abnormal Urinalysis [NA]
The clinical trial evaluating TW for IgA nephropathy with asymptomatic abnormal urinalysis has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-03-03Clinical Trial Update: A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes. [Phase 2]
Phase 2 clinical trial evaluating steroid therapy for IgA nephropathy with active pathological changes; current status is not provided.
-
CLINICAL_TRIALS trial_result · 2014-10-01Clinical Trial Update: Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy [Phase 3]
Phase 3 trial of mycophenolate mofetil in IgA nephropathy was terminated with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-08-21Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy Patients [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of tacrolimus in IgA nephropathy in Korean patients has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: Treatment of IgAN With Multi-glycoside of Tripterygium Wilfordii HOOK. f. [Phase 3]
Phase 3 clinical trial evaluating multi-glycoside of Tripterygium wilfordii Hook. f. for IgA nephropathy; current status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2014-05-15Clinical Trial Update: Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease [Phase 4]
Phase 4 trial evaluating aldosterone breakthrough during Diovan, Tekturna, and combination therapy in proteinuric kidney disease was termina…
-
CLINICAL_TRIALS research · 2013-08-28Clinical Trial Update: An Observational Study of IgA Nephropathy: Pathological Variants and Clinical Data
An observational study assessing pathological variants and clinical data in IgA nephropathy. The study has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy [Phase 4]
A Phase 4 clinical trial assessed probucol in combination with valsartan for IgA nephropathy, and the study has completed.
-
CLINICAL_TRIALS research · 2013-06-17Clinical Trial Update: Study of Standardized Treatment of Integrative Medicine With the Severe IgA Nephropath [NA]
A clinical trial update from Shanghai University of Traditional Chinese Medicine on standardized integrative medicine treatment for IgA neph…